Curis.com provides solutions for controlling pathways to restore health
Title
Curis - Controling regeneration signaling pathways to restore human health
Description
Curis, Inc. is a therapeutic drug development company. The Company’s technology focus is on regulatory pathways that control repair and regeneration. Curis’ product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer (under two collaborations with Genentech, one of which includes a co-development arrangement for a basal cell carcinoma product candidate that is currently in Phase I clinical trials), neurological disorders (under collaboration with Wyeth), hair growth (under collaboration with Procter & Gamble), kidney disease (licensed to Ortho Biotech Products and under development at Centocor, both subsidiaries of Johnson & Johnson), and cardiovascular disease.
Additional Information
Related Domains
- Alopecia
- Amylin
- Anemia
- Bmp
- Biopharmaceuticals
- Biotech
- Biotechnology And Pharmaceuticals
- Cris
- Cur
- Cellular Biology
- Chemotherapy
- Curis
- Dialysis
- Esi
- Genentech
- Genetic Engineering
- Genomics
- Hedgehog
- Hematopoiesis
- Hh
- Human Pharmaceuticals
- Johnson And Johnson
- Kidney Disease
- Medicines
- Molecular Biology
- Neurological Disorders
- Neuroscience
- Ortho Biotech
- Research And Development
- Stem Cells
- 61614
- BMP
- Biotechnology and Pharmaceuticals
- CRIS
- CUR
- ESI
- Research and Development